166 related articles for article (PubMed ID: 38578498)
1. A multimodal clinical diagnostic approach using MRI and
Lavrova A; Pham NTT; Vernon CJ; Carlos AF; Petersen RC; Dickson DW; Lowe VJ; Jack CR; Whitwell JL; Josephs KA
J Neurol; 2024 Apr; ():. PubMed ID: 38578498
[TBL] [Abstract][Full Text] [Related]
2. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
Buciuc M; Botha H; Murray ME; Schwarz CG; Senjem ML; Jones DT; Knopman DS; Boeve BF; Petersen RC; Jack CR; Petrucelli L; Parisi JE; Dickson DW; Lowe V; Whitwell JL; Josephs KA
Neurology; 2020 Jul; 95(1):e23-e34. PubMed ID: 32518145
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.
Botha H; Mantyh WG; Murray ME; Knopman DS; Przybelski SA; Wiste HJ; Graff-Radford J; Josephs KA; Schwarz CG; Kremers WK; Boeve BF; Petersen RC; Machulda MM; Parisi JE; Dickson DW; Lowe V; Jack CR; Jones DT
Brain; 2018 Apr; 141(4):1201-1217. PubMed ID: 29538658
[TBL] [Abstract][Full Text] [Related]
4. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
5. Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes.
Blazhenets G; Frings L; Sörensen A; Meyer PT;
J Nucl Med; 2021 Jun; 62(6):855-860. PubMed ID: 33097630
[TBL] [Abstract][Full Text] [Related]
6. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
Walker JM; Gonzales MM; Goette W; Farrell K; White Iii CL; Crary JF; Richardson TE
J Alzheimers Dis; 2023; 92(3):1037-1049. PubMed ID: 36847012
[TBL] [Abstract][Full Text] [Related]
8. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
[TBL] [Abstract][Full Text] [Related]
9. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy.
Youssef H; Gatto RG; Pham NTT; Petersen RC; Machulda MM; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
J Alzheimers Dis; 2024; 99(3):1023-1032. PubMed ID: 38728190
[TBL] [Abstract][Full Text] [Related]
11. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
12. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
13. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
[TBL] [Abstract][Full Text] [Related]
14. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
Bejanin A; Murray ME; Martin P; Botha H; Tosakulwong N; Schwarz CG; Senjem ML; Chételat G; Kantarci K; Jack CR; Boeve BF; Knopman DS; Petersen RC; Giannini C; Parisi JE; Dickson DW; Whitwell JL; Josephs KA
Brain; 2019 Nov; 142(11):3621-3635. PubMed ID: 31562527
[TBL] [Abstract][Full Text] [Related]
15. Age-related and amyloid-beta-independent tau deposition and its downstream effects.
Wuestefeld A; Pichet Binette A; Berron D; Spotorno N; van Westen D; Stomrud E; Mattsson-Carlgren N; Strandberg O; Smith R; Palmqvist S; Glenn T; Moes S; Honer M; Arfanakis K; Barnes LL; Bennett DA; Schneider JA; Wisse LEM; Hansson O
Brain; 2023 Aug; 146(8):3192-3205. PubMed ID: 37082959
[TBL] [Abstract][Full Text] [Related]
16. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
17. Combined
Aparicio J; Carreño M; Bargalló N; Setoain X; Rubí S; Rumià J; Falcón C; Calvo A; Martí-Fuster B; Padilla N; Boget T; Pintor L; Donaire A
Neuroimage Clin; 2016; 12():976-989. PubMed ID: 27995064
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
Teipel SJ; Temp AGM; Levin F; Dyrba M; Grothe MJ;
J Alzheimers Dis; 2021; 79(2):663-670. PubMed ID: 33337372
[TBL] [Abstract][Full Text] [Related]
20. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
